Hu Shaoxuan について
Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Song Yuqin について
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China について
Sun Xiuhua について
Department of Medical Oncology, The Second Hospital of Dalian Medical University, Dalian, China について
Su Liping について
Department of Hematology, Cancer Hospital of Shanxi Province, Taiyuan, China について
Zhang Wei について
Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Jia Jing について
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China について
Department of Hematology, The First Hospital of Jilin University, Jilin, China について
Yang Sheng について
Department of Medical Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Liang Rong について
Department of Hematology, Xijing Hospital, The Fourth Military Medical University, Xi’an, China について
Li Xiaoling について
Department of Medical Oncology, Liaoning Cancer Hospital and Institute, Shenyang, China について
Zhang Huilai について
Department of Medical Oncology, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China について
Gao Yuhuan について
Department of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China について
Zhang Weijing について
Department of Medical Oncology, 307 Hospital of Chinese People’s Liberation Army, Beijing, China について
Xiao Xiubin について
Department of Medical Oncology, 307 Hospital of Chinese People’s Liberation Army, Beijing, China について
Bao Huizheng について
Department of Medical Oncology, Jilin Cancer Hospital, Changchun, China について
Wang Ningju について
Department of Medical Oncology, General Hospital of Ningxia Medical University, Yinchuan, China について
Ren Hanyun について
Department of Hematology, Peking University First Hospital, Beijing, China について
Cen Xinan について
Department of Hematology, Peking University First Hospital, Beijing, China について
Yang Shun’e について
Department of Medical Oncology, Xinjiang Cancer Hospital, Wulumuqi, China について
Zhao Yu について
Department of Hematology, The General Hospital of Chinese People’s Liberation Army, Beijing, China について
Wang Yinan について
Department of Medical Oncology, The People’s Hospital of Tangshan City, Tangshan, China について
Wang Yalan について
Department of Medical Oncology, Baotou Cancer Hospital, Baotou, China について
Liu Aichun について
Department of Hematology, The Third Hospital of Harbin Medical University, Haerbin, China について
Wang Jingwen について
Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, China について
Shi Yuankai について
Department of Medical Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Yuan Ming について
Illinois Institute of Technology, Chicago, Illinois について
Li Yufu について
Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China について
He Xiaohui について
Department of Medical Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Cancer Science (Web) について
ヒト について
びまん性大細胞型B細胞リンパ腫 について
抄録等の続きを表示するにはログインが必要です。なお医療系文献の抄録につきましてはアカウント情報にて「医療系文献の抄録等表示の希望」を設定する必要があります。
乳房 について
びまん性大細胞型B細胞リンパ腫 について
放射線 について
再発 について
リツキシマブ について
腫ようの治療一般 について
リツキシマブ について
原発 について
乳房 について
びまん性大細胞型B細胞リンパ腫 について
治療戦略 について
成功 について